1.43
前日終値:
$1.54
開ける:
$1.56
24時間の取引高:
263.63K
Relative Volume:
0.36
時価総額:
$110.41M
収益:
$139.77M
当期純損益:
$-97.62M
株価収益率:
-0.9051
EPS:
-1.58
ネットキャッシュフロー:
$-61.71M
1週間 パフォーマンス:
-18.29%
1か月 パフォーマンス:
+12.60%
6か月 パフォーマンス:
-67.13%
1年 パフォーマンス:
-90.25%
Macrogenics Inc Stock (MGNX) Company Profile
名前
Macrogenics Inc
セクター
電話
301-251-5172
住所
9704 MEDICAL CENTER DRIVE, Rockville, MD
MGNX を他の銘柄と比較する
株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
---|---|---|---|---|---|---|
![]()
MGNX
Macrogenics Inc
|
1.43 | 110.41M | 139.77M | -97.62M | -61.71M | -1.58 |
![]()
VRTX
Vertex Pharmaceuticals Inc
|
424.99 | 128.84B | 11.10B | -988.90M | -1.26B | -3.92 |
![]()
REGN
Regeneron Pharmaceuticals Inc
|
527.78 | 65.38B | 14.09B | 4.50B | 2.96B | 39.28 |
![]()
ARGX
Argen X Se Adr
|
549.65 | 39.67B | 2.19B | 833.04M | -1.28B | 12.71 |
![]()
ALNY
Alnylam Pharmaceuticals Inc
|
251.15 | 33.82B | 2.35B | -269.70M | -75.39M | -2.09 |
![]()
ONC
Beigene Ltd Adr
|
231.99 | 27.60B | 3.81B | -644.79M | -669.77M | -6.24 |
Macrogenics Inc Stock (MGNX) Upgrades & Downgrades
日付 | アクション | アナリスト | 評価の変更 |
---|---|---|---|
2024-11-07 | ダウングレード | JMP Securities | Mkt Outperform → Mkt Perform |
2024-08-01 | ダウングレード | BTIG Research | Buy → Neutral |
2024-07-31 | ダウングレード | B. Riley Securities | Buy → Neutral |
2024-07-31 | ダウングレード | Guggenheim | Buy → Neutral |
2024-05-10 | ダウングレード | BMO Capital Markets | Outperform → Market Perform |
2024-05-10 | ダウングレード | Stifel | Buy → Hold |
2024-05-10 | ダウングレード | TD Cowen | Buy → Hold |
2024-04-26 | 開始されました | B. Riley Securities | Buy |
2024-04-09 | アップグレード | TD Cowen | Hold → Buy |
2024-03-04 | 繰り返されました | BTIG Research | Buy |
2024-02-14 | ダウングレード | H.C. Wainwright | Buy → Neutral |
2023-12-20 | アップグレード | Citigroup | Neutral → Buy |
2023-11-07 | アップグレード | Guggenheim | Neutral → Buy |
2023-03-17 | ダウングレード | Guggenheim | Buy → Neutral |
2022-11-22 | ダウングレード | Cowen | Outperform → Market Perform |
2022-11-14 | アップグレード | BMO Capital Markets | Market Perform → Outperform |
2022-07-18 | ダウングレード | SMBC Nikko | Outperform → Neutral |
2022-07-11 | ダウングレード | BMO Capital Markets | Outperform → Market Perform |
2022-05-04 | ダウングレード | Guggenheim | Buy → Neutral |
2022-02-28 | アップグレード | Citigroup | Neutral → Buy |
2022-02-11 | 開始されました | BMO Capital Markets | Outperform |
2022-02-04 | 開始されました | SMBC Nikko | Outperform |
2021-11-17 | 再開されました | Guggenheim | Buy |
2021-10-19 | 開始されました | JMP Securities | Mkt Outperform |
2021-10-15 | 再開されました | BTIG Research | Buy |
2021-04-26 | 再開されました | Credit Suisse | Outperform |
2021-03-12 | アップグレード | Barclays | Underweight → Overweight |
2020-12-22 | 再開されました | H.C. Wainwright | Buy |
2020-08-03 | ダウングレード | Citigroup | Buy → Neutral |
2020-06-01 | アップグレード | Guggenheim | Neutral → Buy |
2020-05-26 | 繰り返されました | H.C. Wainwright | Buy |
2020-03-04 | 開始されました | Barclays | Underweight |
2019-12-19 | 開始されました | Cantor Fitzgerald | Overweight |
2019-12-18 | 開始されました | Cantor Fitzgerald | Overweight |
2019-11-21 | ダウングレード | Morgan Stanley | Equal-Weight → Underweight |
2019-11-20 | 再開されました | Guggenheim | Neutral |
2019-05-03 | アップグレード | Wedbush | Neutral → Outperform |
2019-04-12 | 開始されました | Guggenheim | Neutral |
2019-02-07 | アップグレード | Citigroup | Sell → Buy |
2019-02-07 | ダウングレード | Wedbush | Outperform → Neutral |
2019-02-06 | アップグレード | Raymond James | Underperform → Mkt Perform |
2019-02-04 | ダウングレード | Citigroup | Neutral → Sell |
2018-12-10 | ダウングレード | Raymond James | Outperform → Underperform |
2018-09-10 | 再開されました | BTIG Research | Buy |
2018-05-31 | 開始されました | Evercore ISI | Outperform |
2018-03-05 | 開始されました | H.C. Wainwright | Buy |
2017-03-31 | 開始されました | Raymond James | Outperform |
すべてを表示
Macrogenics Inc (MGNX) 最新ニュース
Class Action Filed Against MacroGenics, Inc. (MGNX)September 24, 2024 Deadline to JoinContact Levi & Korsinsky - ACCESS Newswire
Price T Rowe Associates Inc. MD Decreases Holdings in MacroGenics, Inc. (NASDAQ:MGNX) - The AM Reporter
MGNX LAWSUIT ALERT: Levi & Korsinsky Notifies MacroGenics, Inc. Investors of a Class Action Lawsuit and Upcoming Deadline - ACCESS Newswire
MacroGenics at Citizens JMP Life Sciences Conference: Strategic Pipeline Insights - Investing.com Australia
MacroGenics Announces Date of First Quarter 2025 Financial Results - GlobeNewswire
MacroGenics Announces Date of First Quarter 2025 Financial Resul - GuruFocus
Levi & Korsinsky Reminds MacroGenics, Inc. Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of September 24, 2024MGNX - ACCESS Newswire
MacroGenics, Inc. Class Action: Levi & Korsinsky Reminds MacroGenics Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of September 24, 2024MGNX - ACCESS Newswire
MacroGenics Inc expected to post a loss of 78 cents a shareEarnings Preview - TradingView
Macrogenics Inc: Is MGNX Stock Worth Buying? - Stocksregister
Press Release Distribution & PR Platform - ACCESS Newswire
LPL Financial LLC Sells 8,500 Shares of MacroGenics, Inc. (NASDAQ:MGNX) - Defense World
MacroGenics to Participate in Upcoming Investor Conference | MGN - GuruFocus
MacroGenics to Participate in Upcoming Investor Conference | MGNX Stock News - GuruFocus
MacroGenics to Participate in Upcoming Investor Conference - The Manila Times
MacroGenics Announces Exclusive Fireside Chat at Major Life Sciences ConferenceKey Details Inside - Stock Titan
A year in review: Macrogenics Inc (MGNX)’s performance in the last year - uspostnews.com
Quarterly Snapshot: Quick and Current Ratios for Macrogenics Inc (MGNX) - DWinneX
MacroGenics (MGNX) to Release Earnings on Thursday - Defense World
MacroGenics, Inc. Securities Fraud Class Action Lawsuit Pending: Contact Levi & Korsinsky Before September 24, 2024 to Discuss Your RightsMGNX - ACCESS Newswire
MacroGenics, Inc. (NASDAQ:MGNX) Holdings Increased by Geode Capital Management LLC - Defense World
JPMorgan Chase & Co. Acquires 221,905 Shares of MacroGenics, Inc. (NASDAQ:MGNX) - Defense World
MGNXMacroGenics Provides Update on Corporate Progress and 2024 Financial Results - ADVFN
The MGNX Stock Puzzle: Unraveling Macrogenics Inc’s Fluctuating Performance - investchronicle.com
MacroGenics Provides Update on Corporate Progress and 1st Quarter 2017 Financial Results - ADVFN
MacroGenics Provides Update on Corporate Progress and 2024 Financial Results - ADVFN
Macrogenics Inc (MGNX) 財務データ
収益
当期純利益
現金流量
EPS
大文字化:
|
ボリューム (24 時間):